Journal profile · Pharmacology & Pharmacy
FARMACIA
ISSN 0014-8237 · Romanian Society for Pharmaceutical Sciences · ROMANIA · Bimonthly · Founded 1953
FARMACIA: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.56; fully open access; APC charged, amount not published; review 6–12 weeks (community reports); community-reported acceptance: easy; 130 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
FARMACIA is published by Romanian Society for Pharmaceutical Sciences and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Phytochemistry and Biological Activities, Phytochemicals and Antioxidant Activities and Essential Oils and Antimicrobial Activity, together about 25.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal Overview FARMACIA is a continuously published scientific journals in the pharmaceutical sciences, first issued in 1894. It is the official journal of the Romanian Society of Pharmaceutical Sciences, serving as a national and international platform for the dissemination of multidisciplinary peer-reviewed research in health sciences emphasizing on drug discovery in the context of personalised therapy. The journal is published in both online (ISSN: 2065-0019) and printed (ISSN: 0014-8237) editions and follows rigorous peer-review standards to ensure scientific validity, methodological soundness, and relevance. Types of Articles Published FARMACIA publishes the following categories of scholarly contributions: Original research articles, reporting novel experimental, analytical, or clinical findings Review articles, offering critical and systematic analyses of current advances Editorial commentaries, addressing emerging scientific, regulatory, or methodological issues Short communications and scientific news, relevant to pharmaceutical research and practice All submissions undergo a peer review process and must represent original work that has not been published or submitted elsewhere. Scientific Fields and Research Areas Covered Based on its scope and indexing profile, FARMACIA publishes research across a broad range of pharmaceutical and biomedical sciences, including but not limited to: Adverse drug reactions and toxic effects, from mechanistic to clinical perspectives Biochemistry and molecular biology, particularly as related to drug mechanisms, targets, and metabolic pathways Clinical pharmacy and clinical experience, including pharmacotherapy and rational drug use Drug delivery systems and pharmaceutical technology, covering formulation science, biopharmaceutics, and dispensing practices Drug discovery and development, including synthesis, characterization, and optimization of bioactive compounds Medicinal chemistry, with emphasis on structure–activity relationships Metabolism and pharmacokinetics, including ADME studies and drug–drug interactions Natural products and bioactive substances, including animal-derived, plant-derived, and synthetic compounds Personalised therapies and novel approaches for health improvement Pharmacology and toxicology, encompassing experimental, translational, and applied studies The journal integrates experimental, analytical, and applied research, supporting both fundamental and practice-oriented in health or pharma
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Andreea Letiția ARSENEPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named Romania 33, Spain 2, Türkiye 2, Belgium 2, Greece 2 (51 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences9.1%
- Phytochemicals and Antioxidant ActivitiesMedicine8.6%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences8.3%
- Natural Antidiabetic Agents StudiesMedicine7.4%
- Synthesis and biological activityChemistry6.8%
- Analytical Methods in PharmaceuticalsChemistry4.8%
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics3.8%
- Medicinal plant effects and applicationsMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SSCIESCIWeb of ScienceEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.56LetPub ·
- Impact factor (publisher) 2024
- 1.3Publisher website ·
- 5-year impact factor (publisher)
- 10Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.42LetPub ·
- h-index
- 19LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 167OpenAlex ·
- 2-year mean citedness
- 1.3OpenAlex ·
- Self-citation rate
- 43.8%LetPub ·
- Share of gold OA articles
- 88.5%LetPub ·
Volume
- Articles per year
- 152LetPub ·
Articles by year OpenAlex count · 1,210 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2025 | 130 | 130 | 95 |
| 2024 | 156 | 156 | 277 |
| 2023 | 156 | 156 | 420 |
| 2022 | 156 | 156 | 540 |
| 2021 | 156 | 156 | 801 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | EUR 320 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- RON 1,500
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Keywords
- ≥ 3
- Manuscript length
- ≤ 1,500 words
- Reference style
- Numbered, in order of citation
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Article types accepted2
- original articlesOriginal articles: Human Subjects (human subjects, human materials or data): the research should be conducted according to the Declaration of Helsinki (latest r…Length not stated
- review articlesReview articles: PRISMA guidelinesLength not stated
Policy excerpts from the journal's websiteAuthorship, Publication ethics, Plagiarism
- Authorship
Covering letter and disclosure form signed by all authors required; material must be original and not under consideration elsewhere. Model summary
The covering letter and disclosure form signed by all the authors must state that authors agreed with the submission and that the material is original and is not under the consideration for publication elsewhere.
Source ↗Publisher website ·- Publication ethics
Declaration must state compliance with Declaration of Helsinki or Directive 210/63/EU for clinical studies or animal research. Model summary
The declaration must contain, also, a statement that clinical studies or experimental research on laboratory animals comply with the Declaration of Helsinky or the Directive 210/63/EU.
Source ↗Publisher website ·- Plagiarism
Originality requirement: article must not have been published previously and must be submitted exclusively to FARMACIA. Model summary
The manuscript is only accepted if neither the article nor any essential part of this has been published previously and is submitted exclusively to the journal FARMACIA.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Romanian Society for Pharmaceutical Sciences
- Country or region
- ROMANIA
- Language
- Rumanian
- Frequency
- Bimonthly
- Founded
- 1953
- ISSN
- 0014-8237
- Society / sponsor
- Romanian Society of Pharmaceutical Sciences
- Latest issue on the website
- Volume 74, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about FARMACIA
What CAS zone is FARMACIA in?
In the 2025 upgraded edition of the CAS Journal Ranking, FARMACIA is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of FARMACIA?
The latest impact factor listed by LetPub is 1.56; CiteScore 2.3, h-index 22.
How long does peer review take at FARMACIA?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of FARMACIA?
According to the journal's author guidelines: Keywords: ≥ 3; Manuscript length: ≤ 1,500 words; Reference style: Numbered, in order of citation; Templates: Word; First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of FARMACIA based?
Of the 51 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are Romania (33), Spain (2) and Türkiye (2). Counted from the institutions listed on the board page; for reference only.
Which databases index FARMACIA?
According to LetPub and DOAJ records, FARMACIA is indexed in SCIE and Scopus. The journal's website also lists SSCI, ESCI, Web of Science, Embase and CAS; that list has not been checked against each database.
Is FARMACIA open access, and what is the APC?
FARMACIA is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .